Last month the IChemE Global Awards 2016 were held in Manchester, UK, in one of the biggest celebrations of chemical engineering achievement worldwide. Our judges had a difficult task narrowing down 16 winners from 120 amazing finalists.
The ceremony was held at the Principal Hotel and welcomed over 400 guests from around the world to recognise and celebrate chemical engineering success stories.
For many, success doesn’t end after collecting a trophy, but marks the starting point on a journey to excellence. An IChemE Award can take you to some unexpected places, make commercialisation easier, help to develop your team or grow your portfolio. You could even get a letter from the US President.
So every day this week we’ll be dedicating special blog posts to the 2016 Award winners and their innovative, fascinating, problem-solving projects. With the fantastic support of Morgan Sindall we have produced a video for every one – enjoy!
On 24 May 2016 at the Edinburgh International Conference Centre, Professor Jonathan Seville was inaugurated as IChemE President for 2016-17. The Executive Dean of Engineering at University of Surrey delivered his Presidential Address on the subject of relevance. Jonathan challenged us all to think: how will the Institution and the profession stay relevant in a world that is rapidly changing?
Over the last few years, cycling has seen a meteoric rise in both popularity and participation. Its most gruelling and testing competition, the Tour De France, drew to a close last month with another British victory.
So it seems quite apt to share how chemical engineering plays a part in this sport.
The phrase ‘chemical engineering in cycling’ may raise a few eyebrows. Indeed, some of the ways in which competitors have broken the rules can be – if you’re able to discount the morality of the outcome – seen as impressive feats of human engineering.
I’m sure you’ve heard of blood doping, where athletes improve their aerobic capacity and endurance through either one of the two following ways:
I, like the rest of the world, have been saddened by the devastation caused by the most recent Ebola outbreak in Africa and its wide-reaching consequences.
Unfortunately, there have been many ‘finger-waving’ stories questioning how it can have taken so long for the major pharmaceutical companies to produce a viable treatment or vaccine for the disease.
Sadly, ‘finger-waving’ isn’t the answer when the solutions are complicated and highly regulated.
Sometimes, the media report on the latest breakthroughs. For example, Time recently reported ‘Scientists Develop Drug to Replace Antibiotics’.
This implies that these drugs are available and ready to go, however this distracts us from the fact the article also states ‘researchers hope to create a pill or an injectable version of it in the next five years’.
Anyone who has worked in research will understand how long it actually takes to move these breakthroughs to the next stage and to truly develop them.
IChemE technical vice-president, Jon-Paul Sherlock, has worked in the pharmaceuticals industry for over 15 years and has offered me a brief insight into what the industry is really like for chemical engineers.